eticlopride has been researched along with Amphetamine Abuse in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gold, SJ; McGinty, JF; Schwendt, M | 1 |
| Jones, S; Kauer, JA; Kornblum, JL | 1 |
2 other study(ies) available for eticlopride and Amphetamine Abuse
| Article | Year |
|---|---|
Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Benzazepines; Cerebral Cortex; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Down-Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gq-G11; Male; Neostriatum; Prosencephalon; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; RGS Proteins; RNA, Messenger; Salicylamides; Signal Transduction | 2006 |
Amphetamine blocks long-term synaptic depression in the ventral tegmental area.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Electrophysiology; Long-Term Potentiation; Neural Inhibition; Neuronal Plasticity; Rats; Rats, Sprague-Dawley; Reward; Salicylamides; Synapses; Ventral Tegmental Area | 2000 |